Morphology of myeloproliferative neoplasms
International Journal of Laboratory Hematology · 2023
DOI: 10.1111/ijlh.14086 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Laboratory Hematology, 2023. Verfasst von Zi Yun Ng und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Sciences, The University of Western Australia, Perth, Western Australia, Australia. Hauptthemen laut MEDLINE: Primary Myelofibrosis, Myeloproliferative Disorders, Polycythemia Vera. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The University of Western Australia.
Abstract (Originalsprache)
Myeloproliferative neoplasms (MPN) are a group of clonal haematological malignancies first described by Dameshek in 1957. The Philadelphia‐negative MPN that will be described are polycythaemia vera (PV), essential thrombocythaemia (ET), pre‐fibrotic myelofibrosis and primary myelofibrosis (PMF). The blood and bone marrow morphology are essential in diagnosis, for WHO classification, establishing a baseline, monitoring response to treatment and identifying changes that may indicate disease progression. The blood film changes may be in any of the cellular elements. The key bone marrow features are architecture and cellularity, relative complement of individual cell types, reticulin content and bony structure. Megakaryocytes are the most abnormal cell and key to classification, as their number, location, size and cytology are all disease‐defining. Reticulin content and grade are integral to assignment of the diagnosis of myelofibrosis. Even with careful assessment of all these features, not all cases fit neatly into the diagnostic entities; there is frequent overlap reflecting the biological disease continuum rather than distinct entities. Notwithstanding this, an accurate morphologic diagnosis in MPN is crucial due to the significant differences in prognosis between different subtypes and the availability of different therapies in the era of novel agents. The distinction between “reactive” and MPN is also not always straightforward and caution needs to be exercised given the prevalence of “triple negative” MPN. Here we describe the morphology of MPN including comments on changes with disease evolution and with treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biomedical Sciences, The University of Western Australia, Perth, Western Australia, Australia.
- Haematology Department, Royal Perth Hospital, Perth, Western Australia, Australia.
- Department of Haematology, PathWest Laboratory Medicine, Nedlands, Western Australia, Australia.
ORCID-Profile: Wendy N Erber
Förderung
- The University of Western Australia
Zitieren
APA
Ng, Z. Y., Fuller, K. A., Mazza-Parton, A., & Erber, W. N. (2023). Morphology of myeloproliferative neoplasms. International Journal of Laboratory Hematology. https://doi.org/10.1111/ijlh.14086
Vancouver
Ng ZY, Fuller KA, Mazza-Parton A, Erber WN. Morphology of myeloproliferative neoplasms. International Journal of Laboratory Hematology. 2023. doi:10.1111/ijlh.14086
BibTeX
@article{Ng2023,
author = {Ng, Zi Yun and Fuller, Kathryn A and Mazza-Parton, Allegra and Erber, Wendy N},
title = {Morphology of myeloproliferative neoplasms},
journal = {International Journal of Laboratory Hematology},
year = {2023},
doi = {10.1111/ijlh.14086}
}
EUVIMED